Yushi Hirota (Yuko Okada)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 46

Top Topics

Insulin Resistance

Percutaneous Coronary Intervention

Top Venues

Journal of diabetes investigation

Diabetes, obesity & metabolism

Diabetology international

This page only lists publications with an associated author ORCID identifier.

Publications

Yushi Hirota, Yasumasa Kakei, Junta Imai, Hideki Katagiri, Ken Ebihara, Jun Wada, Junichi Suzuki, Tatsuhiko Urakami, Takashi Omori, Wataru Ogawa
A multicenter, open-label, single-arm trial of the long-term safety of empagliflozin treatment for refractory diabetes mellitus with insulin resistance (EMPIRE-02). Journal of diabetes investigation 15 (9) (2024)
Tomofumi Takayoshi, Yushi Hirota, Akane Yamamoto, Kai Yoshimura, Seiji Nishikage, Mariko Ueda, Wataru Ogawa
Impact of early-morning administration of rapid-acting insulin on the increase in blood glucose levels related to the dawn phenomenon in individuals with type 1 diabetes. Diabetology international 15 (3) (2024)
Tomofumi Takayoshi, Yushi Hirota, Akane Yamamoto, Kai Yoshimura, Seiji Nishikage, Mariko Ueda, Wataru Ogawa
Impact of early-morning administration of rapid-acting insulin on the increase in blood glucose levels related to the dawn phenomenon in individuals with type 1 diabetes. Diabetology international 15 (3) (2024)
Masako Tomimoto, Kenji Tanimura, Naohisa Masuko, Akiko Uchida, Hitomi Imafuku, Masashi Deguchi, Akane Yamamoto, Yushi Hirota, Wataru Ogawa, Yoshito Terai
Problems in screening for gestational diabetes mellitus by measurement of casual blood glucose levels at 24-28 gestational weeks. Journal of diabetes investigation (2024)
Yuta Nakamura, Ichiro Horie, Tadahiro Kitamura, Yoshiki Kusunoki, Kenro Nishida, Akane Yamamoto, Yushi Hirota, Tomoyasu Fukui, Yasutaka Maeda, Masae Minami, Takanori Matsui, Atsushi Kawakami, Norio Abiru
Glucagon secretion and its association with glycaemic control and ketogenesis during sodium-glucose cotransporter 2 inhibition by ipragliflozin in people with type 1 diabetes: Results from the multicentre, open-label, prospective study. Diabetes, obesity & metabolism 26 (5) (2024)
Yushi Hirota, Yasumasa Kakei, Junta Imai, Hideki Katagiri, Ken Ebihara, Jun Wada, Junichi Suzuki, Tatsuhiko Urakami, Takashi Omori, Wataru Ogawa
A multicenter, open-label, single-arm trial of the long-term safety of empagliflozin treatment for refractory diabetes mellitus with insulin resistance (EMPIRE-02). Journal of diabetes investigation 15 (9) (2024)
Yushi Hirota, Yasumasa Kakei, Junta Imai, Hideki Katagiri, Ken Ebihara, Jun Wada, Junichi Suzuki, Tatsuhiko Urakami, Takashi Omori, Wataru Ogawa
A multicenter, open-label, single-arm trial of the long-term safety of empagliflozin treatment for refractory diabetes mellitus with insulin resistance (EMPIRE-02). Journal of diabetes investigation 15 (9) (2024)
Yuta Nakamura, Ichiro Horie, Tadahiro Kitamura, Yoshiki Kusunoki, Kenro Nishida, Akane Yamamoto, Yushi Hirota, Tomoyasu Fukui, Yasutaka Maeda, Masae Minami, Takanori Matsui, Atsushi Kawakami, Norio Abiru
Glucagon secretion and its association with glycaemic control and ketogenesis during sodium-glucose cotransporter 2 inhibition by ipragliflozin in people with type 1 diabetes: Results from the multicentre, open-label, prospective study. Diabetes, obesity & metabolism (2024)
Yuta Nakamura, Ichiro Horie, Tadahiro Kitamura, Yoshiki Kusunoki, Kenro Nishida, Akane Yamamoto, Yushi Hirota, Tomoyasu Fukui, Yasutaka Maeda, Masae Minami, Takanori Matsui, Atsushi Kawakami, Norio Abiru
Glucagon secretion and its association with glycaemic control and ketogenesis during sodium-glucose cotransporter 2 inhibition by ipragliflozin in people with type 1 diabetes: Results from the multicentre, open-label, prospective study. Diabetes, obesity & metabolism 26 (5) (2024)
Yushi Hirota, Yasumasa Kakei, Junta Imai, Hideki Katagiri, Ken Ebihara, Jun Wada, Junichi Suzuki, Tatsuhiko Urakami, Takashi Omori, Wataru Ogawa
A multicenter, open-label, single-arm trial of the long-term safety of empagliflozin treatment for refractory diabetes mellitus with insulin resistance (EMPIRE-02). Journal of diabetes investigation (2024)
Yuka Oi-Yo, Shin Urai, Akane Yamamoto, Tomofumi Takayoshi, Masaaki Yamamoto, Yushi Hirota, Wataru Ogawa
Seasonal fluctuations of CGM metrics in individuals with type 1 diabetes using an intermittently scanned CGM device or sensor augmented pump. Endocrine (2024)
Yuta Nakamura, Ichiro Horie, Tadahiro Kitamura, Yoshiki Kusunoki, Kenro Nishida, Akane Yamamoto, Yushi Hirota, Tomoyasu Fukui, Yasutaka Maeda, Masae Minami, Takanori Matsui, Atsushi Kawakami, Norio Abiru
Glucagon secretion and its association with glycaemic control and ketogenesis during sodium-glucose cotransporter 2 inhibition by ipragliflozin in people with type 1 diabetes: Results from the multicentre, open-label, prospective study. Diabetes, obesity & metabolism 26 (5) (2024)
Hitomi Imafuku, Kenji Tanimura, Naohisa Masuko, Masako Tomimoto, Yutoku Shi, Akiko Uchida, Masashi Deguchi, Kazumichi Fujioka, Akane Yamamoto, Kei Yoshino, Yushi Hirota, Wataru Ogawa, Yoshito Terai
Advantages of sensor-augmented insulin pump therapy for pregnant women with type 1 diabetes mellitus. Journal of diabetes investigation (2023)
Ryotaro Bouchi, Takahiro Sugiyama, Atsushi Goto, Mitsuru Ohsugi, Narihito Yoshioka, Hideki Katagiri, Tomoya Mita, Yushi Hirota, Hiroshi Ikegami, Munehide Matsuhisa, Eiichi Araki, Hiroki Yokoyama, Masae Minami, Katsuya Yamazaki, Hideaki Jinnouchi, Hiroki Ikeda, Hitomi Fujii, Miyuki Nogawa, Masahiro Kaneshige, Kengo Miyo, Kohjiro Ueki
Impact of COVID-19 pandemic on behavioral changes and glycemic control and a survey of telemedicine in patients with diabetes: A multicenter retrospective observational study. Journal of diabetes investigation (2023)
Wataru Ogawa, Yushi Hirota, Shigeru Miyazaki, Tadashi Nakamura, Yoshihiro Ogawa, Iichiro Shimomura, Toshimasa Yamauchi, Koutaro Yokote, null null
Definition, criteria, and core concepts of guidelines for the management of obesity disease in Japan. Endocrine journal 71 (3) (2023)
Naoki Sakane, Yushi Hirota, Akane Yamamoto, Junnosuke Miura, Hiroko Takaike, Sari Hoshina, Masao Toyoda, Nobumichi Saito, Kiminori Hosoda, Masaki Matsubara, Atsuhito Tone, Satoshi Kawashima, Hideaki Sawaki, Tomokazu Matsuda, Masayuki Domichi, Akiko Suganuma, Seiko Sakane, Takashi Murata
Factors associated with hemoglobin glycation index in adults with type 1 diabetes mellitus: The FGM-Japan study. Journal of diabetes investigation 14 (4) (2023)
Wataru Ogawa, Yushi Hirota, Shigeru Miyazaki, Tadashi Nakamura, Yoshihiro Ogawa, Iichiro Shimomura, Toshimasa Yamauchi, Koutaro Yokote, null null
Definition, criteria, and core concepts of guidelines for the management of obesity disease in Japan. Endocrine journal (2023)
Wataru Ogawa, Yushi Hirota, Shigeru Miyazaki, Tadashi Nakamura, Yoshihiro Ogawa, Iichiro Shimomura, Toshimasa Yamauchi, Koutaro Yokote, null null
Definition, criteria, and core concepts of guidelines for the management of obesity disease in Japan. Endocrine journal 71 (3) (2023)
Yuma Motomura, Shin Urai, Yushi Hirota, Naoki Takegawa, Hironori Bando, Masaaki Yamamoto, Hidenori Fukuoka, Masahiro Tsuda, Wataru Ogawa
Type 1 diabetes mellitus affected by potential toxicity from long-term use of nivolumab. Diabetology international 15 (1) (2023)
Naoki Sakane, Yushi Hirota, Akane Yamamoto, Junnosuke Miura, Hiroko Takaike, Sari Hoshina, Masao Toyoda, Nobumichi Saito, Kiminori Hosoda, Masaki Matsubara, Atsuhito Tone, Satoshi Kawashima, Hideaki Sawaki, Tomokazu Matsuda, Masayuki Domichi, Akiko Suganuma, Seiko Sakane, Takashi Murata
Factors associated with hemoglobin glycation index in adults with type 1 diabetes mellitus: The FGM-Japan study. Journal of diabetes investigation 14 (4) (2023)
Yuma Motomura, Shin Urai, Yushi Hirota, Naoki Takegawa, Hironori Bando, Masaaki Yamamoto, Hidenori Fukuoka, Masahiro Tsuda, Wataru Ogawa
Type 1 diabetes mellitus affected by potential toxicity from long-term use of nivolumab. Diabetology international 15 (1) (2023)
Naoki Sakane, Yushi Hirota, Akane Yamamoto, Junnosuke Miura, Hiroko Takaike, Sari Hoshina, Masao Toyoda, Nobumichi Saito, Kiminori Hosoda, Masaki Matsubara, Atsuhito Tone, Satoshi Kawashima, Hideaki Sawaki, Tomokazu Matsuda, Masayuki Domichi, Akiko Suganuma, Seiko Sakane, Takashi Murata
Factors associated with hemoglobin glycation index in adults with type 1 diabetes mellitus: The FGM-Japan study. Journal of diabetes investigation 14 (4) (2023)
Naoki Sakane, Yushi Hirota, Akane Yamamoto, Junnosuke Miura, Hiroko Takaike, Sari Hoshina, Masao Toyoda, Nobumichi Saito, Kiminori Hosoda, Masaki Matsubara, Atsuhito Tone, Satoshi Kawashima, Hideaki Sawaki, Tomokazu Matsuda, Masayuki Domichi, Akiko Suganuma, Seiko Sakane, Takashi Murata
Factors associated with hemoglobin glycation index in adults with type 1 diabetes mellitus: The FGM-Japan study. Journal of diabetes investigation (2023)
Yuma Motomura, Shin Urai, Yushi Hirota, Naoki Takegawa, Hironori Bando, Masaaki Yamamoto, Hidenori Fukuoka, Masahiro Tsuda, Wataru Ogawa
Type 1 diabetes mellitus affected by potential toxicity from long-term use of nivolumab. Diabetology international 15 (1) (2023)
Masaki Suzuki, Shin Urai, Hidenori Fukuoka, Yushi Hirota, Masaaki Yamamoto, Yuko Okada, Naoki Yamamoto, Hiroki Shichi, Yasunori Fujita, Keitaro Kanie, Genzo Iguchi, Yutaka Takahashi, Wataru Ogawa
Relation between the insulin lowering rate and changes in bone mineral density: Analysis among subtypes of type 1 diabetes mellitus. Journal of diabetes investigation 13 (9) (2022)
Yushi Hirota, Yongjin Xu, Akane Yamamoto, Atsuko Matsuoka, Timothy C Dunn, Wataru Ogawa
Type 1 diabetes iron-deficiency anaemia case report and the clinical relevance of red blood cell lifespan-adjusted glycated haemoglobin. Diabetes, obesity & metabolism (2022)
Takehito Takeuchi, Yushi Hirota, Yasushi Nakagawa, Atsuko Matsuoka, Tetsushi Hamaguchi, Yuko Okada, Kazuhiko Sakaguchi, Wataru Ogawa, Masafumi Koga
Glycated albumin (GA) and the GA/HbA1c ratio are higher in diabetic patients positive for insulin antibodies with high binding capacity and low affinity. Diabetology international 13 (1) (2021)
Natsu Otowa-Suematsu, Kazuhiko Sakaguchi, Akihiro Kaneko, Jun Ito, Yasuko Morita, Hiroshi Miura, Tomoko Yamada, Anna So, Hisako Komada, Yuko Okada, Yushi Hirota, Yoshikazu Tamori, Wataru Ogawa
Relation of cardiac function to insulin resistance as evaluated by hyperinsulinemic-euglycemic clamp analysis in individuals with type 2 diabetes. Journal of diabetes investigation (2021)
Jun Ito, Munenobu Nogami, Yasuko Morita, Kazuhiko Sakaguchi, Hisako Komada, Yushi Hirota, Kenji Sugawara, Yoshikazu Tamori, Feibi Zeng, Takamichi Murakami, Wataru Ogawa
Dose-dependent accumulation of glucose in the intestinal wall and lumen induced by metformin as revealed by 18 F-labelled fluorodeoxyglucose positron emission tomography-MRI. Diabetes, obesity & metabolism 23 (3) (2020)
Hiroshi Miura, Kazuhiko Sakaguchi, Natsu Otowa-Suematsu, Tomoko Yamada, Anna So, Hisako Komada, Yuko Okada, Yushi Hirota, Yoshikazu Tamori, Wataru Ogawa
Effects of insulin degludec and insulin glargine U300 on glycaemic stability in individuals with type 1 diabetes: A multicentre, randomized controlled crossover study. Diabetes, obesity & metabolism 22 (12) (2020)
Yasuko Morita, Munenobu Nogami, Kazuhiko Sakaguchi, Yuko Okada, Yushi Hirota, Kenji Sugawara, Yoshikazu Tamori, Feibi Zeng, Takamichi Murakami, Wataru Ogawa
Enhanced Release of Glucose Into the Intraluminal Space of the Intestine Associated With Metformin Treatment as Revealed by [18F]Fluorodeoxyglucose PET-MRI. Diabetes care 43 (8) (2020)
Hiroyuki Yamamoto, Toshiro Shinke, Hiromasa Otake, Hiroyuki Kawamori, Takayoshi Toba, Masaru Kuroda, Yushi Hirota, Kazuhiko Sakaguchi, Wataru Ogawa, Ken-Ichi Hirata
Impact of daily glucose fluctuations on cardiovascular outcomes after percutaneous coronary intervention for patients with stable coronary artery disease undergoing lipid-lowering therapy. Journal of diabetes investigation 12 (6) (2020)
Wataru Ogawa, Yushi Hirota, Takeshi Osonoi, Takahiro Tosaki, Yoshiro Kato, Kazunori Utsunomiya, Rimei Nishimura, Jiro Nakamura
Effect of the FreeStyle Libre™ flash glucose monitoring system on glycemic control in individuals with type 2 diabetes treated with basal-bolus insulin therapy: An open label, prospective, multicenter trial in Japan. Journal of diabetes investigation 12 (1) (2020)
Kenji Sugawara, Yuko Okada, Yushi Hirota, Kazuhiko Sakaguchi, Wataru Ogawa
Relationship between metformin use and vitamin B12 status in patients with type 2 diabetes in Japan. Journal of diabetes investigation 11 (4) (2020)
Naofumi Yoshida, Seiichi Kitahama, Tomoya Yamashita, Yasuko Hirono, Tokiko Tabata, Yoshihiro Saito, Ryohei Shinohara, Hitomi Nakashima, Takuo Emoto, Yushi Hirota, Tetsuya Takahashi, Wataru Ogawa, Ken-Ichi Hirata
Metabolic alterations in plasma after laparoscopic sleeve gastrectomy. Journal of diabetes investigation 12 (1) (2020)
Atsuko Matsuoka, Yushi Hirota, Akihiko Takeda, Minoru Kishi, Naoko Hashimoto, Takeshi Ohara, Satomi Higo, Hiroyuki Yamada, Tomoaki Nakamura, Tetsushi Hamaguchi, Takehito Takeuchi, Yasushi Nakagawa, Yuko Okada, Kazuhiko Sakaguchi, Wataru Ogawa
Relationship between glycated hemoglobin level and duration of hypoglycemia in type 2 diabetes patients treated with sulfonylureas: A multicenter cross-sectional study. Journal of diabetes investigation 11 (2) (2019)
Hiroshi Miura, Kazuhiko Sakaguchi, Yuko Okada, Tomoko Yamada, Natsu Otowa-Suematsu, Anna So, Hisako Komada, Yushi Hirota, Takeshi Ohara, Yasuo Kuroki, Kenta Hara, Tomokazu Matsuda, Minoru Kishi, Akihiko Takeda, Kazuki Yokota, Yoshikazu Tamori, Wataru Ogawa
Effects of ipragliflozin on glycemic control, appetite and its related hormones: A prospective, multicenter, open-label study (SOAR-KOBE Study). Journal of diabetes investigation 10 (5) (2019)
Yasuko Ohara, Yuko Okada, Tomoko Yamada, Kenji Sugawara, Masayuki Kanatani, Hidenori Fukuoka, Yushi Hirota, Takaki Maeda, Naoya Morisada, Kazumoto Iijima, Wataru Ogawa
Phenotypic differences and similarities of monozygotic twins with maturity-onset diabetes of the young type 5. Journal of diabetes investigation 10 (4) (2019)
Wataru Ogawa, Yushi Hirota
Sodium-glucose cotransporter 2 inhibitor-associated diabetic ketoacidosis in patients with type 1 diabetes: Metabolic imbalance as an underlying mechanism. Journal of diabetes investigation 10 (4) (2019)
Hisako Komada, Yushi Hirota, Wataru Ogawa
Glucagon secretions are impaired in patients with fulminant type 1 diabetes. Journal of diabetes investigation 10 (3) (2019)
Takehito Takeuchi, Yasushi Ishigaki, Yushi Hirota, Yutaka Hasegawa, Tohru Yorifuji, Hiroko Kadowaki, Takashi Akamizu, Wataru Ogawa, Hideki Katagiri
Clinical characteristics of insulin resistance syndromes: A nationwide survey in Japan. Journal of diabetes investigation 11 (3) (2019)
Yushi Hirota, Masao Toyoda, Takashi Murata, Junnosuke Miura
Caution is required for the evaluation of the accuracy of continuous glucose monitoring devices. Journal of diabetes investigation 11 (1) (2019)
Hisako Komada, Yushi Hirota, Kazuhiko Sakaguchi, Yoko Okuno, Wataru Ogawa, Susumu Seino
Impaired glucagon secretion in patients with fulminant type 1 diabetes mellitus. Endocrine 63 (3) (2018)
Tetsushi Hamaguchi, Yushi Hirota, Takehito Takeuchi, Yasushi Nakagawa, Atsuko Matsuoka, Masaaki Matsumoto, Hiroyuki Awano, Kazumoto Iijima, Pei Chieng Cha, Wataru Satake, Tatsushi Toda, Wataru Ogawa
Treatment of a case of severe insulin resistance as a result of a PIK3R1 mutation with a sodium-glucose cotransporter 2 inhibitor. Journal of diabetes investigation 9 (5) (2018)
Yushi Hirota, Tomokazu Matsuda, Shinsuke Nakajima, Michinori Takabe, Naoko Hashimoto, Tomoaki Nakamura, Yushi Hirota, Kazuhiko Sakaguchi, Wataru Ogawa
Effects of exenatide and liraglutide on postchallenge glucose disposal in individuals with normal glucose tolerance. Endocrine 64 (1) (2018)
Kenji Sugawara, Kazuhiro Nomura, Yuko Okada, Aki Sugano, Masaaki Matsumoto, Toru Takarada, Atsuko Takeuchi, Hiroyuki Awano, Yushi Hirota, Hisahide Nishio, Yutaka Takaoka, Wataru Ogawa
In silico and in vitro analyses of the pathological relevance of the R258H mutation of hepatocyte nuclear factor 4α identified in maturity-onset diabetes of the young type 1. Journal of diabetes investigation 10 (3) (2018)